Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Neurogene Inc (NASDAQ: NGNE) was $13.05 for the day, down -13.63% from the previous closing price of $15.11. In other words, the price has decreased by -$13.63 from its previous closing price. On the day, 0.65 million shares were traded.
Ratios:
Our analysis of NGNE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 20.84 and its Current Ratio is at 20.84. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on June 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $65.
On June 11, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $54.
On April 29, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $46.Leerink Partners initiated its Outperform rating on April 29, 2024, with a $46 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 13 ’25 when Cvijic Christine Mikail sold 4,501 shares for $16.94 per share. The transaction valued at 76,247 led to the insider holds 72,343 shares of the business.
Samsara BioCapital GP, LLC bought 48,770 shares of NGNE for $1,259,623 on Nov 26 ’24. The 10% Owner now owns 1,717,127 shares after completing the transaction at $25.83 per share. On Nov 22 ’24, another insider, Cvijic Christine Mikail, who serves as the President and CFO of the company, bought 24,000 shares for $20.48 each. As a result, the insider paid 491,400 and bolstered with 76,844 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 200.13 while its Price-to-Book (P/B) ratio in mrq is 0.62.
Stock Price History:
Over the past 52 weeks, NGNE has reached a high of $74.49, while it has fallen to a 52-week low of $6.88. The 50-Day Moving Average of the stock is -7.33%, while the 200-Day Moving Average is calculated to be -54.08%.
Shares Statistics:
A total of 14.85M shares are outstanding, with a floating share count of 11.74M. Insiders hold about 17.67% of the company’s shares, while institutions hold 97.42% stake in the company.
